Indole derivatives useful for the treatment of CNS disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S319000, C514S415000, C514S312000, C546S153000, C546S157000, C546S198000, C546S201000

Reexamination Certificate

active

06890916

ABSTRACT:
The present invention relates to dopamine D4ligands having the general formula Iwherein R1—R10, W, X, Y1—Y4, and n are as described herein.The compounds of the invention are potent dopamine D4receptor ligands.

REFERENCES:
patent: 1 106 605 (2001-06-01), None
patent: 9316073 (1993-08-01), None
patent: 9828293 (1998-07-01), None
patent: 9911619 (1999-03-01), None
patent: 9958525 (1999-11-01), None
patent: 31074 (2000-06-01), None
patent: 0031074 (2000-06-01), None
patent: 0040581 (2000-07-01), None
patent: 0069424 (2000-11-01), None
Chemical Abstract DN 133:17486, also cited as WO 31074.*
Saxena P.R. Pharm. Ther. vol. 66 pp339-68(1995).*
Cecil Textbook of Medicine, 2oth Edition,vol. 2,pp. 1992-1996(1996).*
Joseph T. Coyle, Science vol. 219,1184-90(1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indole derivatives useful for the treatment of CNS disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole derivatives useful for the treatment of CNS disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives useful for the treatment of CNS disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3379502

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.